HeraMED (ASX:HMD) Net Margin % : -1,772.53% (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is HeraMED Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. HeraMED's Net Income for the six months ended in Jun. 2024 was A$-4.84 Mil. HeraMED's Revenue for the six months ended in Jun. 2024 was A$0.27 Mil. Therefore, HeraMED's net margin for the quarter that ended in Jun. 2024 was -1,772.53%.

The historical rank and industry rank for HeraMED's Net Margin % or its related term are showing as below:

ASX:HMD' s Net Margin % Range Over the Past 10 Years
Min: -8416.98 Med: -3568.07 Max: -1117.44
Current: -1442.78

ASX:HMD's Net Margin % is ranked worse than
93.82% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -0.76 vs ASX:HMD: -1442.78

HeraMED Net Margin % Historical Data

The historical data trend for HeraMED's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeraMED Net Margin % Chart

HeraMED Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

-2,153.08

-8,416.98

-6,541.80

-2,225.85

-1,117.44

HeraMED Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Margin %	Get a 7-Day Free Trial							-2,257.29	-2,183.76	-1,090.97	-1,144.70	-1,772.53

Competitive Comparison of HeraMED's Net Margin %

For the Medical Devices subindustry, HeraMED's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HeraMED's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeraMED's Net Margin % distribution charts can be found below:

* The bar in red indicates where HeraMED's Net Margin % falls into.

HeraMED Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

HeraMED's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-6.727	/	0.602
	=	-1,117.44 %

HeraMED's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin	=	Net Income (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-4.839	/	0.273
	=	-1,772.53 %

HeraMED (ASX:HMD) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

HeraMED Net Margin % Related Terms

Thank you for viewing the detailed overview of HeraMED's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

HeraMED Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeraMED Ltd (ASX:HMD) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

201, 697 Burke Road, Suite 4, Camberwell, VIC, AUS, 3124

Website

https://www.hera-med.com

HeraMED Ltd is engaged in developing, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heartbeat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR). It is also focused on the commercialization and deployment of its HeraCARE pregnancy monitoring solution. Geographically, the company generates a majority of its revenue from the United States of America followed by Australia and Israel.

HeraMED Headlines

No Headlines